Comparison of Treatment Modalities in Poor Responders Undergoing IVF

NCT02158689 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Poor Responders

Interventions

DRUG: Letrozole
DRUG: human menopausal gonadotropin (hMG)

Sponsor

Ercan Bastu